Plus more health news
Lilly's experimental diabetes drug shows promise for weight loss |
|
| | | GLP-1-based drugs are here to stay, since they're among the most effective medications for treating obesity and diabetes. So it's no surprise that their pharmaceutical makers are working on next-generation versions. | Eli Lilly reported that in its latest study of retatrutide, which targets three weight hormones, the drug helped people with diabetes lower their blood sugar by up to 2% and lose 16.8% of their starting body weight, far outperforming the placebo group. | | If you have a minute, please take our quick survey to help us better understand who you are and which health topics interest you most. | |
|
| | | | | | | | | | | | If you were forwarded this and want to sign up to receive it daily, click here. Today's newsletter was written by Alice Park and edited by Angela Haupt. | |
|
| | | | Update your email preferences or unsubscribe here © 2026 TIME USA, LLC. All rights reserved. TIME Customer Service, P.O. Box 37508 Boone, IA 50037-0508, United States | | Terms of Service | |
|
|
|
|
|